Joseph J. Schildkraut

Best Publications

• THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE

  Unknown

  3476
  Citations

• Biogenic Amines and Emotion

  Unknown

  869
  Citations

• Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

  Saul M. Schanberg;Joseph J. Schildkraut;George R. Breese;Irwin J. Kopin

  527
  Citations

• Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock

  Geraldine Cassens;Mark Roffman;Alvin Kuruc;Paul J. Orsulak

  387
  Citations

• Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.

  Joseph J. Schildkraut;Paul J. Orsulak;Alan F. Schatzberg;Jon E. Gudeman

  291
  Citations

• Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

  Joseph J. Schildkraut

  278
  Citations

• Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

  A I Green;S V Zimmet;R D Strous;J J Schildkraut

  245
  Citations

• Catecholamine metabolism in affective disorders—III

  Unknown

  240
  Citations

• The effects of psychoactive drugs on norepinephrine-3H metabolism in brain

  S.M. Schanberg;J.J. Schildkraut;I.J. Kopin

  209
  Citations

• Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New Treatment

  David V. Sheehan;James H. Coleman;David J. Greenblatt;Kenneth J. Jones

  197
  Citations

• Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study.

  Joseph Biederman;David B. Herzog;Timothy M. Rivinus;Gordon P. Harper

  192
  Citations

• Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline

  Alan F. Schatzberg;Alan F. Schatzberg;Alan H. Rosenbaum;Paul J. Orsulak;Paul J. Orsulak;William A. Rohde;William A. Rohde

  189
  Citations

• Norepinephrine Metabolism and Drugs Used in the Affective Disorders: A Possible Mechanism of Action

  Joseph J. Schildkraut;Saul M. Schanberg;George R. Breese;Irwin J. Kopin

  187
  Citations

• Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion

  Robert Watson;Ernest Hartmann;Joseph J. Schildkraut

  186
  Citations

• Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine.

  Joseph J. Schildkraut;Andrew Winokur;Clarence W. Applegate

  179
  Citations

• Neuropsychopharmacology and the Affective Disorders

  Unknown

  167
  Citations

• The effects of lithium ion on H3 -norepinephrine metabolism in brain

  Joseph J. Schildkraut;Saul M. Schanberg;Irwin J. Kopin

  163
  Citations

• The effects of lithium salts on the turnover and metabolism of norepinephrine in rat brain

  Joseph J. Schildkraut;Mayada A. Logue;George A. Dodge

  158
  Citations

• THE EFFECTS OF PENTOBARBITAL ON THE FATE OF INTRACISTERNALLY ADMINISTERED NOREPINEPHRINE-H3

  Saul M. Schanberg;Joseph J. Schildkraut;Irwin J. Kopin

  154
  Citations

• Catecholamine metabolism in affective disorders: I.

  Unknown

  135
  Citations